Foley Catheter Plus Oxytocin Does Not Speed Delivery

Share this content:
Foley Catheter Plus Oxytocin Does Not Speed Delivery
Foley Catheter Plus Oxytocin Does Not Speed Delivery

THURSDAY, Dec. 14, 2017 (HealthDay News) -- The use of a transcervical Foley catheter plus oxytocin does not shorten the time to delivery in women with prelabor rupture of membranes compared with oxytocin alone, according to a study published online Dec. 7 in Obstetrics & Gynecology.

A. Dhanya Mackeen, M.D., M.P.H., from Geisinger in Danville, Pennsylvania, and colleagues randomly assigned women at 34 weeks of gestation or greater with prelabor rupture of membranes to a transcervical Foley catheter inflated to 30 cc with concurrent oxytocin infusion (n = 93) or oxytocin infusion alone (n = 108) for labor induction and cervical ripening.

The researchers found that time to delivery was similar between the groups (13.9 hours in the Foley group versus 14.4 hours in the oxytocin group (P = 0.69). There were more cases of clinical chorioamnionitis in the Foley group compared with the oxytocin group (8 percent versus 0 percent; P < 0.01). All other outcomes, including other infectious morbidities, were similar between the groups.

"In patients with prelabor rupture of membranes, the use of a transcervical Foley catheter in addition to oxytocin does not shorten the time to delivery compared with oxytocin alone, but may increase the incidence of intra-amniotic infection," conclude the authors.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »